Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Sonntag, 12.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

MYLAN INC

WKN: 868270  ISIN: US6285301072  Ticker-Symbol: MYL 
Branche
Pharma
Aktienmarkt
NASDAQ-100
S&P 500
NASDAQ Biotech
1-Jahres-Chart
MYLAN INC Chart 1 Jahr
1-Woche-Intraday-Chart
MYLAN INC 1-Woche-Intraday-Chart

Aktuelle News zur MYLAN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
10.02. 210
CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced Friday that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion Pharmaceuticals Inc., f/k/a Sepracor...
Mehr lesen zu:
Jury Rules Against Mylan In Sunovion Pharma Patent Litigation
10.02. 144
PITTSBURGH, Feb. 10, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion...
Mehr lesen zu:
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution
10.02. 1
09.02. -
09.02. 61
PITTSBURGH, Feb. 9, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) CEO Heather Bresch today testified before the U.S. House of Representatives Energy and Commerce Committee at a hearing hosted by the...
Mehr lesen zu:
Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
09.02. 33
CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer
09.02. 28
CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. obtained final approval from the U.S. Food and Drug Administration, or FDA, for its Abbreviated...
Mehr lesen zu:
Mylan Unit Secures Final FDA Nod For First Generic Version Of Doryx Tablets
09.02. -
09.02. -
09.02. 18
PITTSBURGH, Feb. 9, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food...
Mehr lesen zu:
Mylan Receives Final FDA Approval for First Generic Version of Doryx® Tablets, 150 mg
08.02. 2
08.02. 1
07.02. 1
06.02. 35
CANONSBURG (dpa-AFX) - Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) on Monday said it has completed the divestiture of 1 percent clindamycin and 5 percent benzoyl peroxide gel...
Mehr lesen zu:
Valeant Completes Divestiture Of Generic Dermatology Products To Mylan
06.02. 9
MISSISSAUGA, Ontario, Feb. 6, 2012 /PRNewswire/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of1% clindamycin and 5%...
Mehr lesen zu:
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
06.02. 10
PITTSBURGH, Feb. 6, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that it has successfully completed the acquisition of two dermatological products from Valeant...
Mehr lesen zu:
Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
03.02. 4
03.02. 2
02.02. 36
CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) said its subsidiary Mylan Laboratories Ltd. received tentative approval from the U.S. Food and Drug Administration, or FDA, for its Abbreviated New...
Mehr lesen zu:
Mylan Gets Tentative FDA Approval For Generic Version Of Lipitor
02.02. -
Seite: 1 2 3 4 5 ... Weiter>>
135 Nachrichten in den letzten 6 Monaten